These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4013136)

  • 41. Purification and characterization of guinea pig antithrombin III.
    Clement LT
    Prep Biochem; 1983; 13(1):1-20. PubMed ID: 6856582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].
    Nowak-Göttl U; Groll A; Kreuz WD; Brand M; Breddin HK; von Loewenich V; Kornhuber B
    Klin Padiatr; 1992; 204(3):134-40. PubMed ID: 1614177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The transient increase of plasma thrombin-antithrombin III (TAT) complex levels in patients with congenital antithrombin III deficiency during antithrombin III administration is due to extraction of thrombin from fibrin.
    Kario K; Matsuo T; Kabayashi H; Matsuo M; Yamamoto K
    Thromb Res; 1991 Aug; 63(4):469-72. PubMed ID: 1755000
    [No Abstract]   [Full Text] [Related]  

  • 44. Severely heated therapeutic factor VIII concentrate of high specific activity.
    Winkelman L; Owen NE; Evans DR; Evans H; Haddon ME; Smith JK; Prince PJ; Williams JD; Lane RS
    Vox Sang; 1989; 57(2):97-103. PubMed ID: 2506696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antithrombin-III assay without influence of heparin cofactor II.
    Enomoto M; Tanimizu I; Sakuragawa N
    Thromb Res; 1990 Mar; 57(5):729-36. PubMed ID: 2339367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical problems posed by the consumption of antithrombin III induced by heparin].
    Ferrer F; Augereau B; Angebault M; Vergoz D
    Phlebologie; 1984; 37(1):77-81. PubMed ID: 6718507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").
    Sambrano JE; Jacobson LJ; Reeve EB; Manco-Johnson MJ; Hathaway WE
    J Clin Invest; 1986 Mar; 77(3):887-93. PubMed ID: 3512602
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pre-operative coagulopathy management of a neonate with complex congenital heart disease: a case study.
    Stammers AH; Rauch ED; Willett LD; Newberry JW; Duncan KF
    Perfusion; 2000 Mar; 15(2):161-8. PubMed ID: 10789572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antithrombin III concentrates--are they clinically useful?
    Lechner K; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):340-8. PubMed ID: 7667814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolation and characterization of a hereditary abnormal antithrombin III 'Antithrombin III Toyama'.
    Koide T; Takahashi K; Odani S; Ono T; Sakuragawa N
    Thromb Res; 1983 Jul; 31(2):319-28. PubMed ID: 6636046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of Thrombate III®, a pasteurized and nanofiltered therapeutic human antithrombin concentrate.
    Cai K; Osheroff WP; Buczynski G; Hotta J; Lang J; Elliott E; Lee DC; Roth NJ
    Biologicals; 2014 May; 42(3):133-8. PubMed ID: 24477183
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antithrombin III in hip surgery].
    Weber U; Schöndorf TH; Rettig H
    Z Orthop Ihre Grenzgeb; 1984; 122(1):16-9. PubMed ID: 6702257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Congenital deficiencies of anticoagulant proteins (antithrombin III and protein C).
    Mannucci PM; Tripodi A; Mari D
    Haematologica; 1984; 69(6):730-46. PubMed ID: 6441751
    [No Abstract]   [Full Text] [Related]  

  • 55. A functional abnormal antithrombin III (AT III) deficiency: AT III Charleville.
    Aiach M; Nora M; Fiessinger JN; Roncato M; François D; Gelas MA
    Thromb Res; 1985 Sep; 39(5):559-70. PubMed ID: 4082101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate.
    Büller HR; ten Cate JW
    Am J Med; 1989 Sep; 87(3B):44S-48S. PubMed ID: 2679070
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update.
    Rodgers GM
    Thromb Haemost; 2009 May; 101(5):806-12. PubMed ID: 19404531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Thrombosis patients with familial antithrombin-III deficiency treated with heparin and antithrombin].
    Brandt P
    Ugeskr Laeger; 1981; 143(34):2145-8. PubMed ID: 7281335
    [No Abstract]   [Full Text] [Related]  

  • 59. A highly purified antithrombin III concentrate prepared from human plasma fraction IV-1 by affinity chromatography.
    Lebing WR; Hammond DJ; Wydick JE; Baumbach GA
    Vox Sang; 1994; 67(2):117-24. PubMed ID: 7801599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma.
    Ofosu FA; Modi G; Cerskus AL; Hirsh J; Blajchman MA
    Thromb Res; 1982 Nov; 28(4):487-97. PubMed ID: 7164033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.